Neogen Corporation (NASDAQ:NEOG) experiences strong stock movement, surpassing key benchmarks. The company continues to see active institutional interest, reflecting its importance in the diagnostics ...

Zoetis (NYSE:ZTS) shares fell 1.55% Monday after the animal health company announced it will acquire Neogen Corporation’s (NASDAQ:NEOG) animal genomics business for $160 million. The transaction will ...

Animal health company Zoetis and Neogen Corporation, a food and animal safety solution provider, have entered into a definitive acquisition agreement. Under the $160 million deal, ...

Animal health company Zoetis is to buy Neogen’s global animal genomics business in a deal worth about A$238m.The message ...

If you are wondering whether Neogen is still attractively priced after its recent recovery, this article will walk you through the key valuation checks in plain language. Neogen's share price recently ...

Acquisition strengthens Zoetis’ leadership in Precision Animal Health by integrating Neogen’s global genomics capabilities, expanding predictive insights and individualized care worldwide.

Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today it has entered into a definitive agreement to sell its global genomics business to Zoetis Inc.

Zoetis Inc. announced on March 2 that it has entered into a definitive agreement with Neogen Corporation to acquire Neogen's animal genomics business for $160 million, subject to customary closing ...

Zoetis Inc. expects to close the acquisition of Neogen Corp.’s animal genomics business in the second half of 2026.

According to MarketsandMarkets™, the Food Pathogen Safety Testing Equipment & Supplies Market is projected to reach USD 13.25 ...

Investing.com -- Shares of Zoetis Inc (NYSE:ZTS) fell 1.1% to $129.72 in premarket trading on Monday after the animal healthcare company announced an agreement to acquire Neogen Corporation’s ...

Zoetis Inc., a leading global animal health company, announced a definitive agreement to acquire the animal genomics business of Neogen Corporation for $160 million. The move supports Zoetis’ ...